The date of payment from buyers deliver within days
Company ProfileHangzhou Go Top Peptide Biotech Co.,Ltd.
By certification [File Integrity]
Thymosin α1 CAS NO.62304-98-7 (Tα1, ) is a 28 amino acid peptide fragment derived from prothymosin alpha, a protein that in humans is encoded by the PTMA gene. In immunomodulating therapy, The peptide can exert a positive immunomodulatory effect by activating the dendritic cell MyD88 pathway. It can also play a negative immunomodulatory role by stimulating the dendritic cell IDO (indoleamine-2-3 dioxygenase) pathway, depending on the state of the body. Thymosin α1 is an excellent immunomodulator.
Thymosin alpha 1 has been approved in 35 developing countries for the treatment of Hepatitis B and C. It is also used to boost the immune response in the treatment of other diseases. So far, as COVID-19 pandemic outbreaks globally, COVID-19 drug selection has also included the potential benefits of Thymosin alpha 1(Tα1, Thymosin α1), which has an outstanding effect in immune-modulation in patients.
Remark: For Research Use Only. Not for human use.
CAS list Number 62304-98-7
Catalog Number GT-B005
Molecular Formula C129H215N33O55
Molecular Weight 3108.3